Fresenius Kabi Glycopyrrolate, Lidocaine and Naropin Injections
Fresenius Kabi Glycopyrrolate, Lidocaine and Naropin Injections contain particulate matter.
Moderate risk
Taking it may cause temporary or medically reversible health problems. Serious harm is unlikely.
FDA Class II recall · How risk is rated
2 photos
What happened
Fresenius Kabi USA, LLC, of Lake Zurich, Illinois, recalled five injectable products because hair was found in the products. The products are Naropin (ropivacaine hydrochloride Injection, USP), Xylocaine (lidocaine HCl Injection, USP), Lidocaine HCl Injection, USP, and Glycopyrrolate Injection, USP. The recall began July 16, 2026, and was added to the FDA's Enforcement Report on July 23, 2026. Distribution was nationwide within the USA.
Summary by Recall Canary from the FDA notice.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the list below, then check the codes the FDA notice also names.
Naropin (ropivacaine hydrochloride Injection, USP), 0.5%
Reason: Presence of Particulate Matter: Hair was found in products
- Strength
- 100 mg
- Lot
- 6133436
Xylocaine (lidocaine HCl Injection, USP), 1%
Reason: Presence of Particulate Matter: Hair was found in products
- Strength
- 200 mg
- Lot
- 6130235
- Strength
- 500 mg
- Lot
- 6133986
Lidocaine HCl Injection, USP, 2%
Reason: Presence of Particulate Matter: Hair was found in products
- Strength
- 100 mg
- Lot
- 6133801
Glycopyrrolate Injection, USP
Reason: Presence of Particulate Matter: Hair was found in product
- Strength
- 1 mg
- Lot
- 6134349
- 6134620
From the FDA notice
NDC Tray: 63323-578-05; NDC Vial: 63323-578-07
Details
- Company began the recall
- Sold in
Nationwide within in the USA
- Event ID
- 99449
- Recall numbers
- D-0725-2026 to D-0729-2026
- Company
- Fresenius Kabi USA, LLCLake Zurich, Illinois
- Hazard
- Foreign material
- Recall type
- Voluntary: Firm initiated
- Customers told by
- Letter
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated
